Adaptimmune Quarterly report pursuant to Section 13 or 15(d)

Revenue - Collaboration Agreement - The Genentech Collaboration and License Agreement (Details)

Revenue - Collaboration Agreement - The Genentech Collaboration and License Agreement (Details)	Mar. 31, 2022 USD ($)
Collaboration and License Agreement
Aggregate amount of the transaction price that is allocated to performance obligations that are unsatisfied or partially satisfied under the agreements	$ 386,381,000
Strategic Collaboration and License Agreement
Collaboration and License Agreement
Aggregate amount of the transaction price that is allocated to performance obligations that are unsatisfied or partially satisfied under the agreements	306,227,000
Strategic Collaboration and License Agreement \| Research Service Rights Granted for Initial Off the Shelf Collaboration Targets
Collaboration and License Agreement
Aggregate amount of the transaction price that is allocated to performance obligations that are unsatisfied or partially satisfied under the agreements	188,941,000
Strategic Collaboration and License Agreement \| Research Service Rights Granted for Personalized Therapies
Collaboration and License Agreement
Aggregate amount of the transaction price that is allocated to performance obligations that are unsatisfied or partially satisfied under the agreements	97,758,000
Strategic Collaboration and License Agreement \| Material Right to Designate the Additional Off the Shelf Collaboration Target
Collaboration and License Agreement
Aggregate amount of the transaction price that is allocated to performance obligations that are unsatisfied or partially satisfied under the agreements	13,182,000
Strategic Collaboration and License Agreement \| Material Right for First Option Extend the Research Term
Collaboration and License Agreement
Aggregate amount of the transaction price that is allocated to performance obligations that are unsatisfied or partially satisfied under the agreements	5,077,000
Strategic Collaboration and License Agreement \| Material Right for Second Option Extend the Research Term
Collaboration and License Agreement
Aggregate amount of the transaction price that is allocated to performance obligations that are unsatisfied or partially satisfied under the agreements	$ 1,269,000